By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


 

Imara 

700 Technology Square, 3rd Floor

Cambridge  Massachusetts  02139  U.S.A.
Phone: 1-617-231-6021 Fax: n/a


SEARCH JOBS

Imara Inc., is dedicated to developing novel therapeutics for people living with sickle cell disease and other hemoglobinopathies. Sickle cell disease is a rare, genetic blood disease that causes red blood cells to sickle and become damaged, activating immune cells and blocking blood flow in capillaries, injuring many organs and causing daily pain. Imara is developing IMR-687, a highly selective, potent small molecule inhibitor of phosphodiesterase-9 (PDE9i), to treat patients with sickle cell disease. Imara was launched following an 18-month scientific collaboration between orphan drug accelerator Cydan Development and H. Lundbeck A/S.

YEAR FOUNDED:

2016

LEADERSHIP:

Founder and CEO: James McArthur

CLINICAL TRIAL:

Please click here for clinical trial information.


Key Statistics


Email: info@imaratx.com
Ownership: Private

Web Site: Imara
Employees:
Symbol: 
 



Industry
Biotechnology






Company News
//-->